Torrent Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Torrent Pharma - Not Just Healthcare But Lifecare
One of their notable products is SITAGLIPTIN PHOSPHATE MONOHYDRATE USP, with a corresponding US DMF Number 32333.
Remarkably, this DMF maintains an Active status since its submission on January 19, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 09, 2018, and payment made on December 28, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II